Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer
@article{ATM123168,
author = {Bruno de Paula and Eliana Abdelhay and Carlos Augusto Moreira de Sousa and Susanne Crocamo},
title = {Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer},
journal = {Annals of Translational Medicine},
volume = {12},
number = {3},
year = {2024},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/123168}
}